A double-blind, randomized, placebo- and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasis-Reference-Cited by-同舟云学术

A double-blind, randomized, placebo- and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasis

Published:2020-11-09 Issue:24 Volume:133 Page:2905-2909
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Cai Lin,Chen Gen-Hui,Lu Qian-Jin,Zheng Min,Li Yu-Zhen,Chen Jin,Zheng Jie,Zhang Fu-Ren,Yu Jian-Bin,Yang Sen,Li Fu-Qiu,Xiao Sheng-Xiang,Sun Qiu-Ning,Xu Jin-Hua,Gao Xing-Hua,Fang Hong,Gao Tian-Wen,Hao Fei,Liu Quan-Zhong,Tu Ya-Ting,Li Ruo-Yu,Wang Bao-Xi,Deng Dan-Qi,Zheng Qing-Shan,Liu Hong-Xia,Zhang Jian-Zhong

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference16 articles.

1. Psoriasis;Mounsey;Br J Hosp Med,2018

2. Update on the pathophysiology of psoriasis;Hugh;Cutis,2018

3. Skin microbiome: an actor in the pathogenesis of psoriasis;Wang;Chin Med J,2018

4. A systematic review of worldwide epidemiology of psoriasis;Michalek;J Eur Acad Dermatol Venereol,2017

5. Diagnosis and management of psoriasis;Kim;Can Fam Physician,2017

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Aryl Hydrocarbon Receptor in the Pathogenesis and Treatment of Psoriasis;Journal of Cutaneous Medicine and Surgery;2024-03-18

2. Traditional Chinese Medicine Shi-Bi-Man ameliorates psoriasis via inhibiting IL-23/Th17 axis and CXCL16-mediated endothelial activation;Chinese Medicine;2024-03-01

3. New and Emerging Oral/Topical Small-Molecule Treatments for Psoriasis;Pharmaceutics;2024-02-06

4. Tapinarof cream for the topical treatment of plaque psoriasis in adults;Expert Review of Clinical Immunology;2023-12-20

5. Efficacy and Safety of Newer Topical Therapies in Psoriasis: A Systematic Review and Network Meta-Analysis;Dermatology;2023-11-08